Empowering Diabetes Patients Beyond the Pandemic
July 28, 2020
Lately, my diabetes patients have been asking questions with no easy answers.
In Conversation: A Physician Discusses COVID-19 & Diabetes Care
June 1, 2020
John Anderson, MD, discusses COVID-19 and diabetes care in this Alliance for Patient Access interview. Read Interview
Capping Insulin Co-pays Could Help Fight COVID-19
March 30, 2020
I have been a doctor for 35 years and I have seen a lot of crises. But I have never seen the country’s health care resources strained the way they are right now.
New Label Could Fix Medicaid’s Insulin Pen Misstep
January 9, 2020
An updated label from the Food and Drug Administration now discourages pharmacies from dividing prepackaged cartons into individual pens before distributing.
Can ICER Put a Value on Diabetes Management?
October 5, 2019
A new report from the Institute for Clinical and Economic Review says oral semaglutide treatment for people with Type 2 diabetes isn’t cost effective.
Uncertainty Plagues ICER Report on Type 2 Diabetes
October 4, 2019
Just one thing stands between some Type 2 diabetes patients and disease management: a dislike of needles.
Diabetes, Deductibles & the IRS
August 15, 2019
People living with diabetes might soon have better access to care thanks to an unlikely source: the Internal Revenue Service.
Out-of-Pocket Costs Are Pushing Patients to the Brink
March 20, 2019
It happened again just last week. A patient cried as she explained to me that she can’t afford the out-of-pocket cost of her medicine.
Congressional Diabetes Caucus Confronts Insulin Affordability
November 14, 2018
A new white paper from the Congressional Diabetes Caucus reinforces what patients and advocates know all too well — the insulin pricing system is too complicated, the negotiations are too secretive and the cost for patients is too high.
« Previous 1 2 3 4 Next »